TLSI:NASDAQ, TriSalus Life Sciences, Inc.
TLSI stock overview
TriSalus Life Sciences, Inc. (TLSI:NASDAQ) closed at $3.59 on October 23, 2026,
down 1.91% on the day.
The stock trades 54.8% below its 52-week high of $7.95
and 63.2% above its 52-week low of $2.20.
Over the past year, it lost 29.9%.
TriSalus Life Sciences, Inc. is part of the Finance sector.
Key figures
- Price
- $3.59
- Day change
- -1.91%
- Volume
- 78,402
- Average volume
- 264,534
- Market cap
- 221M+
- 52-week range
- $2.20 – $7.95
- 50-day average
- $4.63
- 200-day average
- $4.47
Price action over the past year
In 252 trading sessions since October 23, 2025, TLSI closed higher on 121 days (48%).
Its best day was February 20, 2026 (+18.22%) and its worst was May 13, 2026 (-41.45%).
The stock moved 10% or more in a single session 8 times.
It opened at least 5% above the previous day's high 2 times.
Recent signals
TLSI news
-
Oct 20, 2026:
TriSalus Life Sciences to Host Third Quarter 2026 Financial Results Conference Call
-
Sep 23, 2026:
TriSalus Life Sciences Shares Rise 15.6% After FDA Clearance for TriNav Advance
-
Sep 22, 2026:
TriSalus Life Sciences Receives FDA Clearance for TriNav® Advance, Strengthening Comprehensive Pressure-Enabled Drug Delivery™ (PEDD™) Portfolio for Liver Embolization
-
Sep 22, 2026:
TriSalus Life Sciences Receives FDA Clearance for TriNav Advance, Strengthening Comprehensive Pressure-Enabled Drug Delivery (PEDD) Portfolio for Liver Embolization
-
Aug 31, 2026:
TriSalus Life Sciences to Participate in the H.C. Wainwright & Company 28th Annual Global Investment Conference
-
Aug 18, 2026:
TriSalus Highlights Tumor-Treatment Expansion, FDA Catalyst at Growth Conference
-
Aug 7, 2026:
TriSalus Life Sciences Q2 Earnings Call Highlights
-
Aug 7, 2026:
TriSalus Life Sciences Inc (TLSI) (Q2 2026) Earnings Call Highlights: New CMS G-code Expands ...
About TriSalus Life Sciences, Inc.
MedTech Acquisition Corp is a blank check company.
Similar stocks
Find more stocks like TLSI with the
Spikes,
Gaps,
Breakouts and
Performance Tracker scanners.
Based on end-of-day data. For information only, not investment advice.